Press Releases

News

News article

AANS 2019

NX Development made an appearance at AANS 2019 in San Diego, CA!

Read More
News article

NX Development Corp. (NXDC) Launches FDA-Approved Gleolan (aminolevulinic acid HCl) for Enhanced Visualization of High-Grade Gliomas (including Glioblastomas)

NX Development Corp. (NXDC) Launches FDA-Approved GleolanTM (aminolevulinic acid HCl) for Enhanced Visualization of High-Grade Gliomas (including Glioblastomas)

Read More
News article

NX Development Corp (NXDC) Announces Merger Acquisition by photonamic GmbH & Co. KG, a German Biotech Firm Engaged in 5-ALA-Related Pharmaceutical Business in Europe

NX Development Corp (NXDC), a privately-held life sciences company, today announced a Merger Acquisition as a result of which NXDC has become a wholly-owned subsidiary of photonamic GmbH & Co. KG

Read More